Swiss National Bank Buys 1,500 Shares of Select Medical Holdings Co. (NYSE:SEM)

Swiss National Bank lifted its stake in Select Medical Holdings Co. (NYSE:SEM) by 0.7% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 217,400 shares of the health services provider’s stock after acquiring an additional 1,500 shares during the period. Swiss National Bank’s holdings in Select Medical were worth $4,098,000 at the end of the most recent quarter.

Other hedge funds have also recently made changes to their positions in the company. Kingsview Wealth Management LLC bought a new position in Select Medical in the third quarter worth about $1,927,000. JPMorgan Chase & Co. grew its position in shares of Select Medical by 9.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 416,299 shares of the health services provider’s stock worth $14,516,000 after buying an additional 36,905 shares during the last quarter. Dynamic Technology Lab Private Ltd bought a new position in shares of Select Medical during the 3rd quarter worth approximately $1,592,000. Argent Capital Management LLC lifted its position in Select Medical by 79.8% during the fourth quarter. Argent Capital Management LLC now owns 55,144 shares of the health services provider’s stock valued at $1,039,000 after acquiring an additional 24,471 shares during the last quarter. Finally, Geode Capital Management LLC boosted its stake in Select Medical by 2.0% in the third quarter. Geode Capital Management LLC now owns 2,442,321 shares of the health services provider’s stock valued at $85,180,000 after acquiring an additional 46,880 shares in the last quarter. 89.48% of the stock is currently owned by hedge funds and other institutional investors.

Select Medical Price Performance

NYSE SEM opened at $17.10 on Wednesday. The stock’s fifty day moving average price is $18.52 and its 200 day moving average price is $25.31. Select Medical Holdings Co. has a 1 year low of $16.20 and a 1 year high of $40.98. The company has a debt-to-equity ratio of 1.37, a current ratio of 1.13 and a quick ratio of 1.13. The company has a market cap of $2.21 billion, a price-to-earnings ratio of 10.36, a PEG ratio of 0.64 and a beta of 1.56.

Select Medical (NYSE:SEM) last announced its quarterly earnings data on Thursday, February 20th. The health services provider reported $0.18 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.29 by ($0.11). Select Medical had a return on equity of 14.04% and a net margin of 3.23%. The firm had revenue of $1.31 billion during the quarter, compared to analysts’ expectations of $1.50 billion. As a group, equities research analysts forecast that Select Medical Holdings Co. will post 1.17 earnings per share for the current year.

Select Medical Cuts Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, March 13th. Stockholders of record on Monday, March 3rd were issued a $0.0625 dividend. This represents a $0.25 annualized dividend and a dividend yield of 1.46%. The ex-dividend date was Monday, March 3rd. Select Medical’s dividend payout ratio (DPR) is currently 15.15%.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on the company. Royal Bank of Canada reduced their price target on Select Medical from $47.00 to $23.00 and set an “outperform” rating on the stock in a research report on Monday, February 24th. UBS Group reduced their target price on Select Medical from $40.00 to $21.00 and set a “neutral” rating on the stock in a research report on Friday, January 3rd. Benchmark raised Select Medical from a “hold” rating to a “buy” rating and set a $23.00 price target for the company in a report on Monday, February 24th. Finally, StockNews.com upgraded shares of Select Medical from a “hold” rating to a “buy” rating in a report on Friday, February 21st. One investment analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat, Select Medical currently has an average rating of “Moderate Buy” and a consensus price target of $27.25.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.